SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-002350
Filing Date
2020-01-08
Accepted
2020-01-08 19:00:49
Documents
1
Period of Report
2020-01-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm201539d1_4.html 4  
1 OWNERSHIP DOCUMENT tm201539d1_4.xml 4 3339
  Complete submission text file 0001104659-20-002350.txt   4832
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37 NEW YORK NY 10001
Business Address
Campagna Jason (Reporting) CIK: 0001793338 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 20516789